Skip to main content
U.S. flag

An official website of the United States government

Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease

Bibliographic

Year of Publication:
2015
Contact PI Name:
Musthafa Mohamed Essa
Contact PI Affiliation:
Department of Food Science and Nutrition, College of Agriculture and Marine Sciences, Sultan Qaboos University, Oman
Co-Authors:
Selvaraju Subash, Mohammed Akbar, Samir Al Adawi, Gilles J. Guillemin
Primary Reference (PubMED ID):
Funding Source:
Research Council of Oman
Study Goal and Principal Findings:

Alzheimer’s disease (AD) is a devastating age-related neurodegenerative disease with no specific treatment at present. The APPsw/Tg2576 mice exhibit age-related deterioration inmemory and learning as well as amyloid-beta (Aβ) accumulation, and this mouse strain is considered an effective model for studying the mechanism of accelerated brain aging andsenescence. The present study was aimed to investigate the beneficial effects of dietary supplements pomegranate, figs, or the dates on suppressing inflammatory cytokines inAPPsw/Tg2576 mice. Changes in the plasma cytokines and Aβ, ATP, and inflammatory cytokines were investigated in the brain of transgenic mice. Significantly enhanced levels ofinflammatory cytokines IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, TNF-α and Eotaxin activity were decreased by administration of the diet supplements containing pomegranates, figs, or dates. In addition, putative delays in the formation of senile plaques, as indicated by a decreasing tendency of brain Aβ1–40 and Aβ1–42 contents, were observed. Thus, novel results mediated by reducing inflammatory cytokines during aging may represent one mechanism by which these supplements exert their beneficial effects against neurodegenerative diseases such as AD. 

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Dietary Interventions & Supplements
Therapeutic Agent:
Pomegranate Juice
Therapeutic Target:
Multi Target
Therapy Type:
Dietary Interventions & Supplements
Therapeutic Agent:
Figs
Therapeutic Target:
Multi Target
Therapy Type:
Dietary Interventions & Supplements
Therapeutic Agent:
Dates
Therapeutic Target:
Multi Target

Animal Model

Model Information:
Species:
Mouse
Model Type:
APP
Strain/Genetic Background:
Not Reported

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Biomarkers
Dose
Formulation
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest

Outcomes

Outcome Measured
Outcome Parameters
Biochemical
Proinflammatory Cytokines
Cytokines
Eotaxin
Brain-Buffer Insoluble beta Amyloid Peptide 40
Brain-Buffer Insoluble beta Amyloid Peptide 42
Brain-Buffer Soluble beta Amyloid Peptide 40
Brain-Buffer Soluble beta Amyloid Peptide 42
Adenosine Triphosphate (ATP)
Interleukin 4 (IL-4)
Interleukin 5 (IL-5)
Interleukin 9 (IL-9)
Interleukin 10 (IL-10)
Interleukin 3 (IL-3)
Interleukin 1 beta (IL-1 beta)
Interleukin 6 (IL-6)
Tumor Necrosis Factor alpha (TNF alpha)
Biomarker
Plasma-Cytokines